| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.395 | 10.238 | 5.366 | 6.822 | 4.640 | 4.783 | 4.753 |
| Total Income - EUR | - | - | - | 6.395 | 10.238 | 5.367 | 6.822 | 4.640 | 4.783 | 4.753 |
| Total Expenses - EUR | - | - | - | 799 | 3.251 | 5.208 | 3.926 | 4.596 | 5.887 | 3.908 |
| Gross Profit/Loss - EUR | - | - | - | 5.596 | 6.987 | 159 | 2.896 | 43 | -1.105 | 845 |
| Net Profit/Loss - EUR | - | - | - | 5.404 | 6.682 | 11 | 2.706 | -75 | -1.147 | 510 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Amc Bella Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 73 | 0 | 0 | 0 | 1.078 | 1.299 | 711 |
| Current Assets | - | - | - | 5.507 | 7.069 | 1.485 | 4.223 | 2.746 | 1.347 | 2.560 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 93 | 6 | 6 | 5 | 5 | 30 | 5 |
| Cash | - | - | - | 5.414 | 7.063 | 1.480 | 4.217 | 2.740 | 1.318 | 2.555 |
| Shareholders Funds | - | - | - | 5.447 | 6.733 | 1.189 | 3.869 | 3.806 | 2.647 | 3.142 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 133 | 362 | 296 | 354 | 17 | 0 | 130 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Amc Bella Med S.r.l.